How Does Altering the Timing of Pre-exercise Low-dose Caffeine Ingestion Affect Endurance Exercise Performance

NCT ID: NCT02985606

Last Updated: 2018-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-11-30

Study Completion Date

2018-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigate how manipulating the time between caffeine ingestion and exercise may alter exercise performance and cognition

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caffeine -60

Caffeine at 60 minutes prior to time trial

Group Type ACTIVE_COMPARATOR

Caffeine powder -60

Intervention Type OTHER

Placebo powder -30

Intervention Type OTHER

Placebo powder 0

Intervention Type OTHER

Caffeine -30

Caffeine at 30 minutes prior to time trial

Group Type ACTIVE_COMPARATOR

Caffeine powder -30

Intervention Type OTHER

Placebo powder -60

Intervention Type OTHER

Placebo powder 0

Intervention Type OTHER

Caffeine 0

Caffeine immediately prior to time trial

Group Type ACTIVE_COMPARATOR

Caffeine powder 0

Intervention Type OTHER

Placebo powder -60

Intervention Type OTHER

Placebo powder -30

Intervention Type OTHER

Placebo

Placebo drink at all time points

Group Type PLACEBO_COMPARATOR

Placebo powder -60

Intervention Type OTHER

Placebo powder -30

Intervention Type OTHER

Placebo powder 0

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Caffeine powder -60

Intervention Type OTHER

Caffeine powder -30

Intervention Type OTHER

Caffeine powder 0

Intervention Type OTHER

Placebo powder -60

Intervention Type OTHER

Placebo powder -30

Intervention Type OTHER

Placebo powder 0

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* vo2max \> 55 ml/kg/min
* females on contraceptive pill

Exclusion Criteria

* recent skeletal muscle injury
* cardiovascular injury
* metabolic disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Exeter

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sport and Health Sciences

Exeter, Devon, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Davenport AD, Jameson TSO, Kilroe SP, Monteyne AJ, Pavis GF, Wall BT, Dirks ML, Alamdari N, Mikus CR, Stephens FB. A Randomised, Placebo-Controlled, Crossover Study Investigating the Optimal Timing of a Caffeine-Containing Supplement for Exercise Performance. Sports Med Open. 2020 Mar 30;6(1):17. doi: 10.1186/s40798-020-00246-x.

Reference Type DERIVED
PMID: 32232597 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

181739/02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.